Ceritinib (LDK378): a potent alternative to crizotinib for ALK-rearranged non-small-cell lung cancer (Q38280122)
Jump to navigation
Jump to search
scientific article published on 13 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ceritinib (LDK378): a potent alternative to crizotinib for ALK-rearranged non-small-cell lung cancer |
scientific article published on 13 October 2014 |
Statements
1 reference
Ceritinib (LDK378): a potent alternative to crizotinib for ALK-rearranged non-small-cell lung cancer (English)
1 reference
Sen Li
1 reference
Xiaolong Qi
1 reference
Yufeng Huang
1 reference
Dingfeng Liu
1 reference
Fangyu Zhou
1 reference
Caicun Zhou
1 reference
13 October 2014
1 reference
1 reference
16
1 reference
2
1 reference
86-91
1 reference
Identifiers
1 reference
1 reference